Be part of the social media conversation

Social Media in Pharma Summit: The Web's Largest Online Social Media in Pharma Conference

Maximizing your digital assets and medical communication strategies to gain actionable insights from your patient base

Meet your Speakers

Click on a photo to view their bio
 
  • Peter J. Pitts
  • Eileen O’Brien
  • Alex Butler
  • Daisy Chhatwal
  • Ellen Hoenig-Carlson
  • Ioannis Karageorgos
  • John Pugh
  • Aimee Kalnoskas
  • Arik Flanders
  • Denis Costello
  • Tai Spargo, MPA
  • Line Berg Østergaard
  • Ray Chepesiuk
  • Jean Samuel
  • Michael Fadus
  • Neil Osmond
  • Paul Dixey
  • Tim Lloyd
  • Chris Brogan
  •  Michael A. Ibara
  • Craig H. Lipset
  • Xavier Petit
  • Samuel Dyer
  • Serkan Erkovan

5 Steps in 5 Minutes To Build Your Social Media Strategy

Marketing and social media authority Chris Brogan explains what you need to when developing your social media plan. In these 5 videos Chris looks at: Which Networks You Should Use; Why You Should Make Your Patient a “Hero”; The Concept of the PharmaWall; The Importance of Listening & Connections Referrals Awareness and Presence.

Remember you can ask Chris your questions live and direct on July 28 as part of the Summit – register now and learn from the experts

  

 

“Patients are engaging in online conversations about medications whether pharma participates or not.”(Source: Drug Safety Alliance, November 2010)

In today's virtual world, social media conversations are having a direct impact on pharmaceutical sales and brand reputations. Every day patients are questioning their treatment options often and making product choices based on online conversations, many of which consist of un-edited and un-qualified user generated content.

With the increased popularity of tools such as Twitter, Facebook and other online communities, patients and their caregivers are able to interact with each other, as well as healthcare providers and pharmaceutical companies from across the global in real-time. They are doing so in unprecedented numbers. For many patients the first place they seek medical information is online.

On the other hand patients are also sharing invaluable information online about their thought processes and behavior. If utilised correctly, these insights can potentially help all functions of drug development - from R&D to pharmacovigilance - to produce more effective and safer treatments.

This is where we are delighted to come in...

Pharma IQ is proud to present Social Media in Pharma Summit, the first ever social media online event for the pharmaceutical community.

This interactive online event will bring together an international panel of thought leaders to discuss and debate the challenges and opportunities social media presents for the pharmaceutical industry – all of this in a convenient online format.

During the series of webinars, participants can see who is 'logged in' to the event and initiate a private chat to exchange ideas and contact details.

This 100% online event begins July 12 and runs through August 4, 2011.

In order to accommodate your schedule, we have spread this event over the course of a month so that you may attend at your convenience. Simply log in to 2-3 sessions, twice a week.  Presentations will also be recorded and available on-demand. Should you miss a session, you will always have an opportunity to catch up at a time that is convenient!

Be sure to secure your spot on the only online summit looking at the opportunities for social media in pharma.

We look forward to seeing you online!

Andrea Charles
Editor
Pharma IQ

P.S Don't miss this rare opportunity to join three interactive panel discussions looking at navigating the complex regulatory landscape, pharma's responsibility for information in social media and successful strategies for patient communications.






Event Highlights



Just a few of the event highlights:  
 

  • Get a unique behind-the-scenes look at how Facebook fits in Boehringer Ingelhiem’s ‘unstrategy’ and how to stay abreast of technological advancements that will impact your social media strategy
     
  • Learn the potential risks when a trial patient is actively involved in social media from Pfizer and discuss the potential for convergence between the e-patient and e-participant
     
  • Learn cross-industry and take advantage of this chance to quiz Texas Instruments on how they unified their social media and created internal guidelines as to how to use social media effectively
     
  • Gain insights into how NORD and EURORDIS are uniting the rare disease community through social media and meeting the important goals of support and information sharing within a specific rare disease community
     
  • Explore how future relationships between patient, provider and the government with change from the UK Department Health
  • Are you mobile? Assess the impact of mobile on social media adoption with Shire US and find out what you can do with mobile in Canada from the Commissioner of the Pharmaceutical Advertising Advisory Board
  • Looking for buy-in? Learn how to "sell" social media internally with Zimmer


WHO:

This event is ideal for C-level management, vice presidents, directors, managers, and professionals  focused on the following areas: social media, marketing, digital strategy, product management, brand management/ strategy, advertising and promotion, compliance, regulatory affairs, pharmacovigilance, patient safety, e-communications, medical communications, patient communications and health policy. 


WHAT:

This interactive event brings together for the first time online, an internationally recognized panel of social media thought leaders and experts to discuss how pharmaceutical and medical device companies can maximize their digital assets and improve their patient communication and community engagement strategies via social media to gain actionable intelligence and insights from consumers/ patients.   


WHERE:

In the comfort of your home or office! No traveling expenses or timing conflicts. This online event takes place by using your computer or laptop.


WHEN:

Beginning July 12 (spread over one month to improve learning and accommodate your schedule; scroll down for the full agenda). All sessions are recorded so if you can't make a particular session, don't worry, you'll have access to all sessions to view at your convenience.


WHY:


“Patients are engaging in online conversations about medications whether pharma participates or not.”
(Source: Drug Safety Alliance, November 2010)


 


HOW:

Simply register by clicking on any of the links throughout this page.



How it Works



Is this your first online event? Don’t worry. Joining the rest of the pharmaceutical social media community could not be easier. Here’s how it works:

1. This online event showcases LIVE, real-time presentations.

Our entire speaker faculty will be presenting their knowledge and expertise on social media strategies via your computer. From the comfort of your home or office, you can listen and watch the presentations in real-time and interact with the speaker and other customer management professionals that share similar challenges. And if your schedule isn't flexible to the LIVE presentations, don't worry; you will receive ALL sessions on-demand so that you can participate at your convenience.

2. Interact with the presenters and additional social media professionals LIVE!

Unlike pre-recorded webinars, this event gives you the opportunity to interact with the experts in real-time. Presentations and discussions take place the moment you log on, and if you have questions or comments while the event is taking place…just ask and you'll get a response instantly!

3. Networking is a key contributor to knowledge sharing...

Often times when you go to conferences, you exchange business cards with many pharmaceutical or social media professionals. Usually the conversation stops once you pack up and head back to work. Not here! This online event not only gives you the chance to meet pharmaceutical and social media professionals that are in the same boat as you, you'll be able to have extensive discussions, live ongoing interactivity and continuous sharing of best practices.

Don't forget to join our LinkedIn group where you can network and continue to interact with professionals like yourself. (Our LinkedIn Group is Pharma IQ - The Network for Pharma & Biotech Professionals...)

Take full advantage of our event-focused Twitter-based chat stream (the hash tag for this event is #socialphrm) where you can interact live with your peers while the event is taking place.

We understand that you don't have much time in your busy schedule, so we have designed this event to best accommodate your participation!  We have expanded this online event over the course of 4 weeks, with four sessions scheduled per week.

And if you can't make it, you'll have access to anything you missed! The recordings will be available for you to view at any time.





Agenda



Available
Now
Social Media & Pharma: New Frontier or Wild West?
Peter J. Pitts
  •  FDA guidance will provide little guidance: what to do when expected regulatory emancipation does not materialize
  • Understanding how fear of adverse event discovery may be a blessing in disguise
  • It’s content not platform that counts
  • The specter of sponsorship
  • Social media is not digitized DTC
Speaker:
Peter J. Pitts, President, Center for Medicine in the Public Interest, Advisor to Obama Administration FDA Transition Team , Former Associate Commissioner, US Food and Drug Administration


 

Available
Now
Panel Discussion: The Rules of Engagement – Can Regulated Businesses Like Pharma and Healthcare Embrace Social Media?
Eileen O’Brien
Alex Butler
Daisy Chhatwal
Ellen Hoenig-Carlson

Pharma is not leveraging social media anywhere as much as it could be. One of the main inhibitors for the industry is the complex compliance arena. Take part in this interactive panel to discuss how navigate the regulatory landscape and gain clarity on the lines you can't cross with regards to social media.

  • Is social media right for Pharma?
  • How can pharma get started in social media? What are the first steps? 
  • Who in pharma is doing a good job of using social media?
  • What are some industry best practices?
     
Panelists:
Eileen O’Brien, Director, Search & Innovation, Siren Interactive
Alex Butler, EMEA Marketing Communications Manager, EMEA Strategic Marketing, Janssen
Daisy Chhatwal, Senior Manager Regulatory Affairs , MedImmune
Ellen Hoenig-Carlson, Founding Partner , AdvanceMarketWoRx


 

Available
Now
Panel Discussion: Do Patients Want to Have a Conversation with a Drug Company?
Eileen O’Brien
Ioannis Karageorgos

The patient is now playing a greater role in their own healthcare. They are engaging and forming communities, with or without the pharmaceutical and healthcare industry. They are not just seeking health information online in unprecedented numbers, but making decisions about their diagnosis, treatment and after-care based on the information receive online. This panel discusses how and when to engage with the patient online.

Panelists:
Eileen O’Brien, Director, Search & Innovation, Siren Interactive
Ioannis Karageorgos, Senior Protocol Data Manager , Bristol-Myers Squibb R&D


 

Available
Now
A Facebook Case Study
John Pugh
  • We heart Facebook
  • How Facebook fits into our ‘Unstrategy’
  • Why we use, you know, like, normal, language?
  • Wedontmoderatecommentsandtheskyhasntfallendown (or, at least, I haven’t been sacked yet)
  • The future just happened and we didn’t miss it
Speaker:
John Pugh, Director of Digital Communications , Boehringer Ingelheim


 

Available
Now
Cross-Industry Case Study: How Texas Instruments Unifies Social Media
Aimee Kalnoskas
Arik Flanders
  • Breakdown of social media usage at TI
  • Defining your social media strategy
  • Creating guidelines and training as to how to use social media effectively
Panelists:
Aimee Kalnoskas , WW Manager, Community & Social Media, Texas Instruments (TI)
Arik Flanders, Social Media Program Manager, Texas Instruments (TI)


 

Available
Now
NORD and EURORDIS: Uniting Communities through Social Media
Denis Costello
Tai Spargo, MPA

Patients in the rare disease community often feel isolated. Support systems such as patient organizations and online communities are integral in helping to diminish those feelings.

  • Discuss how rare diseases are increasingly being recognized as an international public health challenge, and the struggles and experience of patients is often similar regardless of which country they reside in.
  • Understand how social media presents an opportunity for patients and their families to connect regardless of physical location and other limitations.
  • Find out more about the Rare Disease Communities, a joint project of the National Organization for Rare Disorders (NORD) and the European Organization for Rare Disorders (EURORDIS) to create disease-specific online patient communities on which individuals can read information about their disease, share and read stories from other patients, find the organizations that specialize in their disease, and network with others across five different languages.
  • Discover how Rare Disease Communities seeks to help patients and disease specific patient organizations connect to strengthen international collaboration and to meet the important goals of support and information sharing within a specific rare disease community.
Panelists:
Denis Costello, Web Communications Officer, European Organization for Rare Disorders (EURORDIS)
Tai Spargo, MPA, Special Projects Coordinator, National Organization for Rare Disorders (NORD)


 

07/19
11:15 AM EST
Leveraging Social Media Platforms to Enhance Patient Relationships
Eileen O’Brien
  • Understanding how your patient base interacts online 
  • How to engage with your patient group online
  • Gaining actionable insights into your patient
Speaker:
Eileen O’Brien, Director, Search & Innovation, Siren Interactive


 

Available
Now
Inside Job: Gaining Internal Acceptance and Support for New and Social Media
Line Berg Østergaard
  • Understanding existing employee social media behavior – individual vs. representative, personal vs. professional
  • Overcoming internal challenges and recognizing commercial opportunities to effectively communicate the benefits of social media
  • Getting “buy-in” by creating an advocacy ladder
  • Lessons learnt
Speaker:
Line Berg Østergaard, Interactive and New Media Manager, Zimmer


 

Available
Now
Digital Brand Strategy in the NOW Economy: Proactive and Real Time
Ellen Hoenig-Carlson
  • The NOW Economy demands that marketers can respond real-time
  • Strong digital brand strategy requires a process that builds upon ‘deep’ foundations to conserve and grow brand strength
  • 5 imperatives to boost your Digital IQ—the new Critical Success Factors (CSFs) for success with web 2.0 and health 2.0 customers
  • Go. Initiate. When was the last time you did something for the first time? Hint: an iterative approach may work best
Speaker:
Ellen Hoenig-Carlson, Founding Partner , Advance MarketWoRx


 

Available
Now
The Role of PAAB in Social Media Marketing for Pharma
Ray Chepesiuk
  • Gain an insight into the Canadian Drug Advertising Regulatory System and the role of  the Pharmaceutical Advertising Advisory Board (PAAB).
  • What advertising regulations apply to social media?
  • What can you do with mobile in Canada?
  • Canadian case examples. good and not so good
Speaker:
Ray Chepesiuk, Commissioner and Chief Executive Officer , Pharmaceutical Advertising Advisory Board, (PAAB)


 

Available
Now
Panel Discussion: Is it Time for Policies to Dictate Social Media Participation?
Jean Samuel
Line Berg Østergaard
Michael Fadus
Neil Osmond
Paul Dixey

Where the lines of jurisdiction and responsibility are blurred, pharma has been thrust into the unfamiliar realm of self-governance. This panel discusses embedding compliance into your social media activities and creating an internal social media policy.

  • Do you think social media needs to be managed by policies or is it more an IT technical issue, like e-mail?
  • In your opinion which of the social media trends raises the most need for some sort of social media participation policy?
  • Does your company have/ intend to have a social media policy? If yes, is it general policy for all staff or is there a marketing component?
  • Where in the set of company policies would you address the social media participation issues? In a stand-alone policy or integrated into other policies/SOPs e.g. educational services to medicine; patient support programs?
     
Panelists:
Jean Samuel, Director, STEP-IN Management
Line Berg Østergaard, Interactive and New Media Manager, Zimmer
Michael Fadus , Regional Compliance Director , Merck
Neil Osmond , Operations Director, Earthware
Paul Dixey, Managing Partner, Bluelight Partners


 

Available
Now
Navigating the Channels of Social Media and Looking at How Future Relationships Between the Patient, Provider and Government will Change
Tim Lloyd
  • Examples of how social media can be used to deliver better patient care
  • Ideas and examples of how to engage with the public about health issues
  • Pitfalls and unsolved questions: what issues still need to be addressed around social media and health?
Speaker:
Tim Lloyd, Deputy Head of Publishing and e-Communications, UK Department of Health


 

Available
Now
Online Social Presence in the World of Pharma
Chris Brogan
  • How to build a social presence online. 
  • What to know about listening specifically in the pharma world
  • The four major uses of social media in online marketing for pharma
  • Some major don'ts to avoid
  • First steps to getting started using social business tools for pharma
Speaker:
Chris Brogan, President , Human Business Works


 

Available
Now
Successfully Incorporating Social Media in a Drug Safety Strategy – Is it Possible?
 Michael A. Ibara
  • How often do posts include adverse events?
  • Challenges of monitoring adverse events via social media
  • Building strategies to effectively handle adverse event
Speaker:
Michael A. Ibara, Head of Pharmacovigilance Information Management , Pfizer


 

Available
Now
The Risks and Rewards of Involving the e-Patient in Clinical Trial Research
Craig H. Lipset
  • Discuss the unique expectations and needs of the e-patient when considering participation in a blinded clinical trial
  • Learn the potential risks when the trial participant is actively involved in social media
  • Discuss the potential for convergence between the e-patient and the e-participant, where apps and self-tracking begin to blend with ePRO and patient reported outcomes

Teaser: Blog post at Pfizer’s Think Science Now  https://science.pfizer.com/content/epatients-and-clinical-trials/

Speaker:
Craig H. Lipset, Head of Clinical Innovation, Worldwide Research & Development, Pfizer


 

Available
Now
Are You Mobile? The Impact of Mobile on Social Media
Xavier Petit
  • Examining key mobile trends
  • Assessing the impact of mobile on social media adoption
  • Implication for marketers: integration and fragmentation
Speaker:
Xavier Petit, Integrated Marketing - Multi-Channel Strategy Services, Shire US


 

Available
Now
Case Study: How to Successfully Utilise Social Media to Connect a Global Community within Pharma
Samuel Dyer
  • Using social media and new online technologies to manage medical science liaison careers
  • How we used social media to help launch the company 
  • How social media helps to establish a connection between medical science liaisons to build a global community
  • Why the power of social media is one of the sources of our continued success
Speaker:
Samuel Dyer, CEO/Founder , MSL WORLD


 

Available
Now
What’s Next for Pharma and Social Media?
Serkan Erkovan
  • Staying abreast of technological advancements that will impact your social media strategy
  • Power shift from physician to patient & payor
  • Realizing Pharma 3.0 and embracing change by small steps
Speaker:
Serkan Erkovan , Lead Business Consultant, Boehringer Ingelheim


 





FAQ's



1. I can't make some of these sessions. Will I be able to get a copy?
Yes. This event is designed so that if you can't attend some presentations, ALL sessions will be made available on-demand so that you can view it at your convenience. Even if you do attend the live sessions, you will get access to all the recordings to keep for your own use.

2. When are the sessions being offered?

The sessions are outlined below for your convenience. Remember...if you can't make it, don't worry; you will still get access to the recording so you won't miss a thing!

  • Tuesday, July 12, 2011, 9.00 am Eastern
  • Tuesday, July 12, 2011, 10:15 am Eastern
  • Thursday, July 14, 2011, 9.00 am Eastern
  • Thursday, July 14, 2011, 10:15 am Eastern
  • Tuesday, July 19, 2011, 9.00 am Eastern
  • Tuesday, July 19, 2011, 10:15 am Eastern
  • Tuesday, July 19, 2011, 11.15 am Eastern
  • Thursday, July 21, 2011, 9.00 am Eastern
  • Thursday, July 21, 2011, 10:15 am Eastern
  • Tuesday, July 26, 2011, 9.00 am Eastern
  • Tuesday, July 26, 2011, 10:15 am Eastern
  • Thursday, July 28, 2011, 9.00 am Eastern
  • Thursday, July 28, 2011, 10:15 am Eastern
  • Thursday, July 28, 2011, 11.15 am Eastern
  • Tuesday, August 2, 2011, 9.00 am Eastern
  • Tuesday, August 2, 2011, 10.15 am Eastern
  • Thursday, August 4, 2011, 9.00 am Eastern
  • Thursday, August 4, 2011, 10:15 am Eastern

3. Will the PowerPoints be available?
All registrants will receive a PDF copy of the PowerPoints prior to each session.

4. When can we get the bonus materials?

Bonus materials are distributed upon registration. You will receive a confirmation letter containing this content.

5. Where is the event?

The event is located from the comforts of your home or office. No hassle of travel or accommodation expenses.

6. How long is each session?

Each session is 1 hour in length. There will be a 15 minute break between each session that will give you the chance to network with those in your session and ask the presenter questions.

7. How do you ask questions during the sessions?

For LIVE sessions, the speakers and attendees are set up with LIVE chat, that way the speaker can directly address any questions you may have pertaining to their presentation. For on-demand sessions, you may visit our interactive LinkedIn Group and catch up on anything you might have missed and ask questions of the speakers and your fellow peers.

8.
What if I have technical questions or any other type of questions, who do I contact?
Should you have any technical difficulties or any questions about the event, you may send an email to customer support at customerservice@pharma-iq.com call us at 877-711-2986 and we will respond immediately to your inquiry.





Let's Look at the Facts



25% of search results for the top brands link to user-generated content. Like it or not, your customers have taken to social media to express their feelings about your brand. Now is the time to engage these customers and assure that widespread, viral sentiment generates increased revenue and customer loyalty, not headaches.

The average person has 195 social media “friends”. Even ignoring the viral capability of social media dialogue, remember that your customers have a direct line to the ears of 200 people. In trying to establish your brand, generate business and rebound from shortcomings, where else can you find such clear influence?

Word of mouth has been deemed nearly six times more effective than television advertisement about shaping consumer opinion. How are you using this knowledge to optimize return on marketing spend and assure your television campaigns are not being nullified by ill-sentiment online?

(source: socialmediatoday.com)





Check out the Early Bird Sale!!



For a limited time... Act Now and save.
If you learn just one strategy on how you can improve your organisation's social media activities, the investment in your professional development will have paid for itself.

Don't Delay - Register today and take advantage of this great savings!

Still have questions? Call us at +1 877–711-2986 or email us at customerservice@pharma-iq.com and we will respond immediately to your inquiry.

This unique opportunity gives you the chance to learn from the industry's most knowledgeable experts.
Act Now and secure your spot today!



Register for this Online Event


 

 

Pricing
 
1 Person
$520
Groups of 3-4 (per person)
$420
Groups of 5+ (per person)
$360
Groups of 10+ (per person)
$299


Already a member? Sign In
All fields are required.
First Name
 
Last Name
Address
 
2nd Address
City
 
Country
Zip
 
State
Email
 
Phone
Job Title
 
Company




Add Another Delegate


Registration for online events also gives you free membership to the Pharma IQ Community. You need this membership to access the online event and it also provides year round information, ideas and interviews from industry leaders plus online networking opportunities!

Payment Policy: Payment is due in full at the time of registration. Your registration will not be confirmed until payment is received and may be subject to cancellation. Discounts cannot be combined and do not apply to registrations that have already been processed.

For IQPC's Cancellation, Postponement and Substitution Policy, please visit
www.iqpc.com/cancellation

©2014 IQPC. All Rights Reserved. Use of this site constitutes acceptance of our Privacy Policy. The format, design, content and arrangement of this site constitute a trademark of IQPC. Unauthorized reproduction will be actionable under the Lanham Act and common law principles. By registering for this event you will become a member of Pharma IQ.



Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Each license is for a term of six (6) months, beginning on the date on which the online event starts, unless another term is specified in the booking confirmation. Access to the event (i) is restricted by IP address to one user per registration; (ii) is intended only for each registrant's individual use; and (iii) may not be shared with other persons or entities, either internally or externally. Should the client attempt to exceed the scope of the license, the client acknowledges that IQPC reserves the right to any course of action up to and including the invoicing the client for non-authorized access and seeking of damages against the Client.

About The Organizer

Pharma IQ (www.pharma-iq.com), a division of IQPC, is an international online community focusing on providing pharmaceutical professionals with knowledge, information and articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical community

Through Pharma IQ, you will be able to access pharmaceutical information resources such as presentations and podcasts, as well as events such as webinars, seminars and conferences.

By signing up to the Pharma IQ membership, you will gain access to our growing database of multimedia presentations from leading pharma practitioners, weekly newsletters to keep you updated on latest pharmaceutical content and Pharma IQ members-exclusive discounts on pharma events that offer solutions to your everyday business problems.

Pharma IQ and IQPC provide useful training courses, conference and expositions for pharmaceutical executives to network and learn the latest pharma business development and trends occurring in organisations today. Pharma IQ focuses on establishing an interactive experience featuring practical, objective and up-to-date insight from pharma industry leaders.

This online platform provides you with the opportunity to promote your brand globally through an extensive database and media partner network, reaching new people in new locations.

Branding, webinar and content series options are extensive and packages can be tailor-made to suit your company’s needs. Packages include complimentary registration, participation in comprehensive pre-event marketing campaigns and tailored marketing strategies to suit your organisation’s size, capabilities and individual requirements.

For sponsorship opportunities or any other questions, contact Byron Reid on 0800 652 2363 or +44 (0) 20 7368 9300

Email: sponsorship@iqpc.co.uk

www.iqpc.com



Sponsor



Woolley Pau

Social media at Woolley Pau

We made our name in healthcare advertising by refusing to do healthcare advertising. Instead we built our business on the belief that healthcare brands deserve exactly the same persuasive communication other brands enjoy. And for us that means knowing how to talk to people.

Now, as the digital revolution brings new channels and challenges, our human touch gives us more of an edge than ever. Healthcare brands can see the potential in social media, they want to be 'part of the conversation', but they will fail unless they earn their place with ideas that are intelligent, engaging and, above all, humanly relevant. It is a job we were born to do.

Let's talk.

Contact socialmedia@woolleypau.co.uk



Presented by:

Share to Facebook Share to Twitter Share to LinkedIn More... Print


Want access to a global audience?
Watch to see why leading companies are using
online events to demonstrate thought leadership
in the eyes of a global prospect base.



For more information call +44 20 7368 9536
or email us: bertan.halil@iqpc.co.uk

Peter J. Pitts

Former Associate Commissioner, US Food and Drug Administration

Peter Pitts is President of the Center for Medicine in the Public Interest and Partner/Director of Global Regulatory Policy & Health Initiatives at Porter Novelli and. From 2002-2004 Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug taskforce and is a Special Government Employee (SGE) consultant to the FDA’s Risk Communications Advisory Committee. In 2010, he was named by Modern Healthcare magazine as one of the 300 “most powerful people in American healthcare.” His comments and commentaries on health care policy issues regularly appear in The New York Times, The Los Angeles Times, The Washington Post, The Wall Street Journal, The Financial Times, Health Affairs, The Boston Globe, The Washington Times, The Chicago Tribune, The Chicago Sun Times, The San Francisco Examiner, Investor’s Business Daily, The Baltimore Sun, The Economist, Nature Biotechnology, The Journal of Life Sciences the BBC World Service, Fox News, and The NewsHour with Jim Lehrer, among others. His book, Become Strategic or Die, is widely recognized as a cutting edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of Coincidence or Crisis, a discussion of global prescription medicine counterfeiting and Physician Disempowerment: A Transatlantic Malaise.

Speaking on: Social Media & Pharma: New Frontier or Wild West?

 

Eileen O’Brien

Siren Interactive

Eileen O’Brien has 15 years of interactive healthcare marketing experience. At Siren Interactive, a relationship marketing agency specializing in rare disease therapies, she leads search strategy, analytics, CRM and social media. Previously, O’Brien was Director of Search, Media & Insights at Compass Healthcare Communications where she developed the social media practice. O’Brien was Director of Interactive Media at Engel Publishing Partners, who produce Med Ad News. She was the Director of eMarketing at Virtua Health and held marketing roles at the University of Pennsylvania Health System, Graduate Hospital and the Rothman Institute. O’Brien studied history at Brown University and received an MS in Organizational Dynamics from the University of Pennsylvania. She is on the Board of Directors of the Greater Philadelphia Chapter of the Healthcare Businesswomen's Association. She moderates the #SocPharm tweetchat on Wednesdays at 8 pm EST which discusses pharma marketing and social media. She can be reached on Twitter at @eileenobrien and blogs at http://sirensong.sireninteractive.com.

Speaking on: Panel Discussion: The Rules of Engagement – Can Regulated Businesses Like Pharma and Healthcare Embrace Social Media?

Panel Discussion: Do Patients Want to Have a Conversation with a Drug Company?

Leveraging Social Media Platforms to Enhance Patient Relationships

 

Alex Butler

Janssen

A global thought leader in health care social media for the pharmaceutical industry with the implementation of a number of innovative projects, including the UK’s first pharma twitter account and the world’s first facebook disease community with open comments and post moderation. A regular speaker and writer for the pharmaceutical, marketing, communications and technology press. According to John Mack Alex is the most followed pharmaceutical company employee on twitter in the world and was the inaugural recipient of the Pharmaguy Global Social Media Pioneer award in 2010 Alex currently works for Janssen as EMEA Marketing Communications Manager, part of the Johnson & Johnson Strategic Marketing team. Passionate about new marketing and advertising models Alex is an invited member of the Wharton University Future Of Advertising Global Advisory Board, based in Philadelphia. www.twitter.com/alex__butler

Speaking on: Panel Discussion: The Rules of Engagement – Can Regulated Businesses Like Pharma and Healthcare Embrace Social Media?

 

Daisy Chhatwal

MedImmune

Ms. Chhatwal is an Associate Director in Regulatory Affairs at MedImmune. She is responsible for providing Advertising and Promotion regulatory strategy support to Commercial teams for marketed products. Prior to MedImmune, she worked as a Scientific Liaison for Sanofi-Aventis, where she provided regional scientific support for key opinion leaders, payers, professional/patient societies and assisted in development of Investigator Initiated Trials. Ms. Chhatwal received her Doctorate in Pharmacy and Bachelor’s degree in Chemistry and Pharmacy from Mass. College of Pharmacy.

Speaking on: Panel Discussion: The Rules of Engagement – Can Regulated Businesses Like Pharma and Healthcare Embrace Social Media?

 

Ellen Hoenig-Carlson

AdvanceMarketWoRx

Ellen Hoenig Carlson has been a leader and brand champion in U.S. and Global Consumer and Pharmaceutical Marketing for over two decades. Ellen is a DTC pioneer; spearheading DTC/P brand marketing initiatives since the FDA regulations changed in 1997 and helping companies to leverage patient insights throughout lifecycle management. While at Bristol Myers-Squibb (BMS), Ellen spanned numerous assignments in US and Global Brand Management, Licensing and Business Development, and Vice President of Direct-to-Consumer/Patient (DTC/P) Marketing. During this time, Advertising Age twice recognized her as one of this country’s 50 Most Powerful Marketing Executives. In 2001, Ellen took her breakthrough approaches and established Advance MarketWoRx, a consulting practice focused on powering professional and consumer healthcare brand growth through traditional and non-traditional marketing: simplifying the complexities of today’s marketplace by forging elegant solutions. You can find her at www.AdvanceMarketWoRx.com, 'Notes from the Back of the Book' blog, or on twitter @ellenhoenig.

Speaking on: Panel Discussion: The Rules of Engagement – Can Regulated Businesses Like Pharma and Healthcare Embrace Social Media?

Digital Brand Strategy in the NOW Economy: Proactive and Real Time

 

Ioannis Karageorgos

Bristol-Myers Squibb R&D

With a Health Visitor and business Mathematics academic background, Yiannis KARAGEORGOS (pronounced Kara-yi-ô-rgos) left his native Greece and ended up working in Clinical Data Management like most of us do: By accident. What was a temporary assignment became a true calling, and for the past 15 years Yiannis has worked for a major CRO and a major Pharma company, dealing with all aspects of data management: data collection and validation, medical encoding, 3rd party data integration, metrics definition and creation, database design, edit check programming, statistical programming (mapping and Tables and Listings generation), system integration, validation and user acceptance. Yiannis is hooked on Standards and a member of the Society for Clinical Data Management (SCDM), the representative for Belgium in the International Network of Clinical Data Management Associations (INCDMA) and actively participating at the Electronic Health Records for Clinical Research working group (eClinical Forum/EHRCR team).

Speaking on: Panel Discussion: Do Patients Want to Have a Conversation with a Drug Company?

 

John Pugh

Boehringer Ingelheim

John Pugh, is Director of Digital Communications at Boehringer Ingelheim’s Global Centre in Germany. With a background as a journalist and Internet start-up entrepreneur, he has over 17 year’s media experience, 10 of them in digital. John is responsible for Boehringer Ingelheim’s global social media strategy and is regularly cited as a global thought leader in the field. You can find him online at Twitter.com/JohnPugh or facebook.com/JohnPugh

Speaking on: A Facebook Case Study

 

Aimee Kalnoskas

Texas Instruments (TI)

Aimee is the WW Manager for Community and Social Media at Texas Instruments, a position she has held since April 2010. Aimee joined TI’s analog communications department in 2009 providing media relations support to the high-speed and high-precision data converters and amplifiers group. She is an expert in technical communication and content development for both traditional and new media. An innovator in media-channel exploitation, Aimee has 25 years experience in the electronics and scientific trade press, with senior roles in editorial management and publishing operations including Editor-in-Chief and Strategic Editorial Director. Ms. Kalnoskas has served as a panelist at numerous industry events and as moderator for many webcasts serving the electronics industry. She is the creator and editorial director of a successful series of online, electrical-engineering tutorial programs.

Speaking on: Cross-Industry Case Study: How Texas Instruments Unifies Social Media

 

Arik Flanders

Texas Instruments (TI)

Arik Flanders is TI's Social Media Program Manager. Arik graduated with a BS of Business from Indiana University and an MBA through Ball State University. He joined TI in October 2009 and is responsible for developing, creating, and implementing TI's social media initiatives.

Speaking on: Cross-Industry Case Study: How Texas Instruments Unifies Social Media

 

Denis Costello

European Organization for Rare Disorders (EURORDIS)

Denis Costello is a patient advocate and online communications manager at Eurordis (Rare Diseases Europe), a leading European patient-led non-profit organisation. His role at EURORDIS includes leading digital projects which enhance international collaboration amongst rare disease patient groups and raising public awareness of rare diseases. One such project is www.rarediseasecommunities.org a bespoke social network in 5 languages for patients and families living with rare diseases. Denis is also responsible for the international dimension of the online awareness campaign associated with Rare Disease Day which takes place annually on the last day of February. More information at www.rarediseaseday.org Prior career experiences include running his own technology firm and hosting a daily radio show dedicated to classical music on Irish national radio.

Speaking on: NORD and EURORDIS: Uniting Communities through Social Media

 

Tai Spargo, MPA

National Organization for Rare Disorders (NORD)

Tai Spargo is the Special Projects Coordinator for the National Organization for Rare Disorders (NORD). Her responsibilities include maintaining NORD’s social marketing presence, grant writing, program planning and implementation in support of the many diverse endeavors NORD fosters. Before joining NORD she worked at the U.S. Department of Transportation’s Federal Highway Administration in the Office of Transportation Policy Studies. Additionally she has been in positions at non-profits, a local Council of Governments, a Congressional Office, and a political consulting firm. She graduated from the School of Public Affairs at American University in Washington, DC with a Masters in Public Administration and a Bachelor's of Arts in Interdisciplinary Studies: Communications, Legal Institutions, Economics, and Government.

Speaking on: NORD and EURORDIS: Uniting Communities through Social Media

 

Line Berg Østergaard

Zimmer

Line has focused her career on working with Communications in the pharmaceutical and medical device industry. In 2010 she changed her role as Communications Channel Manager at Nycomed to Interactive Communications and New Media Manager at Zimmer. Today she is leading a global Interactive Communications and New Media team, who are currently working on projects such as changing the global web presence, using iPads to enable competitive selling and moving the company into the social media area. She is passionate about great communications and works everyday to change things for the better. Line has a MA in Communication and Business Studies. She believes that work life balance is achievable and enjoys snowboarding, yoga and generally just nurturing her geek within. Line is Danish but lives in Zurich, Switzerland, she is a bit of a world traveler and usually says that she can work everywhere as long as there is a internet connection. She blogs for the Digital Pharma Blog. You can follow her on Twitter or connect with her on LinkedIn.

Speaking on: Inside Job: Gaining Internal Acceptance and Support for New and Social Media

Panel Discussion: Is it Time for Policies to Dictate Social Media Participation?

 

Ray Chepesiuk

Pharmaceutical Advertising Advisory Board, (PAAB)

Ray is the Commissioner and Chief Executive Officer of the autonomous Pharmaceutical Advertising Advisory Board and is responsible for operations and the administration of the preclearance review mechanism. He has held management positions in community, hospital and government pharmacy and served on the Ontario College of Pharmacists Council, chairing five committees. Ray achieved a Pharmacy degree from the University of Toronto, a Master in International Business (Marketing) degree from the University of South Carolina and a Medical Marketing Certicate from UCLA. He is a Certified Association Executive by the Canadian Society of Association Executives. He has received a United Nations medal for peacekeeping which led to the Nobel Peace Prize in 1996 for all U.N. peacekeepers. He was inducted into the Canadian Healthcare Marketing Hall of Fame in 2009.

Speaking on: The Role of PAAB in Social Media Marketing for Pharma

 

Jean Samuel

STEP-IN Management

Jean has worked in the pharmaceutical industry for over 20 years, and is currently an interim manager addressing business compliance and records management with a special interest in e-marketing, Joint Working and the UK Bribery Act. Former positions include Compliance Director for Schering Plough UK and Head of Clinical Programming and Medical Writing at Pfizer’s UK R&D. In previous roles Jean had responsibility for the development of GCP SOPs, Training and Clinical Trial process improvement, was Inspection Readiness lead during an MHRA inspection and was part of an EFPIA Task Force addressing the secondary use of Electronic Health Records for clinical trials and the privacy and data standards issues this concept raises.

Speaking on: Panel Discussion: Is it Time for Policies to Dictate Social Media Participation?

 

Michael Fadus

Merck

Michael Fadus is an American and recently became a Swiss citizen. He has 18 years of corporate achievement in the US, Germany, Switzerland, and major markets in western, central and eastern Europe. Michael is a US attorney licensed in California, with an MBA degree from Thunderbird, a bachelor’s degree from Boston University, and a master’s degree and law degree from the University of Texas. His past professional experiences include working at major law firms in California and Germany, as in-house counsel and VP of HR in Connecticut (USA), and almost 6 years at the headquarters of Zurich Financial Services in related global roles in compliance, HR, and communications. In 2007 Michael switched to the pharmaceutical industry. He is employed at Merck & Co., Inc. in Lucerne, Switzerland, where he is Regional Compliance Director managing a team of 13 full-time compliance professionals handling compliance in over 60+ countries in Eastern Europe, Middle East, and Africa. He enjoys bridging cultural gaps and has presented at global events on how to succeed across national, ethnic, and corporate borders. When not regaling management about the importance of anti-corruption controls, Michael relaxes by traveling to places with limited mobile phone coverage, and tries his hand (and eye) at photography – on land and under the sea. Some of his photos and underwater videos can be seen at http://swisspix.shutterfly.com

Speaking on: Panel Discussion: Is it Time for Policies to Dictate Social Media Participation?

 

Neil Osmond

Earthware

Neil started his pharmaceutical career with ZS Associates as an Analyst before moving to SmithKline Beecham (SB) with roles in Business Information and Commercial groups. He then moved to a more people focused role, as an HR Consultant and Team Leader with Hewitt Associates before returning to pharmaceuticals, joining AstraZeneca in 2003. Neil had four roles in AstraZeneca culminating in Head of Business Insight before pursuing his passion for technology by starting The Technology Studio. The Technology Studio develops a range of software solutions (web sites, mobile sites, apps) across a range of markets (healthcare, property, travel) and their portfolio of clients include Microsoft, Financial Times, MSD & AstraZeneca. They have developed industry leading, award winning websites such as PharmaField.co.uk, GoLearnTo.com and NovaLoca.com, many of which have social media at the core of their business models. They have also successfully run internal social media campaigns including a recent YouTube campaign that achieved over half a million views of their video within two weeks.

Speaking on: Panel Discussion: Is it Time for Policies to Dictate Social Media Participation?

 

Paul Dixey

Bluelight Partners

Paul Dixey –Managing Partner- BlueLight Partners Paul has over 28 years of pharmaceutical, sales, marketing and communications experience working for companies such as Wellcome, Boots, BASF Pharma, AstraZeneca, Organon and Schering-Plough. Experienced in developing both global strategies and ensuring effective delivery though close collaboration with local affiliates Paul has extensive international and cross cultural experience having worked in Western /Central/Eastern Europe, Francophone Africa, Scandinavia, USA, and Japan. Since setting up his own consultancy Paul has advised and worked with a number of major healthcare companies on building creative and compliant online marketing programmes integrated with their brand or therapy area objectives. Paul has a B.A. Honours Degree in European Business Administration and the equivalent French Diplôme from l’Ecole Supérieure de Commerce de Reims, a leading Grande Ecole in France

Speaking on: Panel Discussion: Is it Time for Policies to Dictate Social Media Participation?

 

Tim Lloyd

UK Department of Health

Tim Lloyd works in the digital communication team at the UK Department of Health. This team is responsible for the way that the Department uses the public web to communicate with healthcare professionals. He also helps to facilitate #nhssm: a weekly webchat with healthcare professionals and communicators on Twitter. Tim is a former editor of European Pharmaceutical Review.

Speaking on: Navigating the Channels of Social Media and Looking at How Future Relationships Between the Patient, Provider and Government will Change

 

Chris Brogan

Human Business Works

Chris Brogan consults and speaks professionally with Fortune 100 and 500 companies like PepsiCo, General Motors, Microsoft, and more, on the future of business communications, and social software technologies. He is a New York Times bestselling co-author of Trust Agents, and a featured monthly columnist at Entrepreneur Magazine. Chris’s blog, [chrisbrogan.com], is in the Top 5 of the Advertising Age Power150. He has over 11 years experience in online community, social media, and related technologies.

Speaking on: Online Social Presence in the World of Pharma

 

Michael A. Ibara

Pfizer

Michael Ibara is responsible for Safety Business Innovation at Pfizer, researching and assessing innovative models for drug safety. His career has been focused on the interface between business, technology and knowledge as it applies to pharmacovigilance and related disciplines. He established one of the first global contract pharmacovigilance functions and consulted on large-scale system implementation and database construction for pharmacovigilance. He was head of Drug Safety for a Biotech company specializing in oncology and aids drugs. At Pfizer he lead implementation of a global safety electronic submissions system and has managed the implementation of large-scale safety technologies. Several years ago he began research on the implications for pharmacovigilance of the electronic medical record and Health2.0, and the possibility of improving public health through novel approaches to pharmacovigilance. His recent work includes designing and co-leading the ASTER project, a collaboration between Partners Healthcare, CDISC, CRIX international, Pfizer, and FDA – to explore a new model for postmarketing safety, and setting up the ASTER Safety Consortium, a group of like-minded companies with a goal to bring ASTER concepts into the real world. He received his Pharm.D. degree from the University of Michigan and completed a Fellowship in Drug Research and Development with Burroughs Wellcome, Inc. and the University of North Carolina and a sabbatical in the Philosophy of Science from Notre Dame University.

Speaking on: Successfully Incorporating Social Media in a Drug Safety Strategy – Is it Possible?

 

Craig H. Lipset

Pfizer

Craig H. Lipset is Head of Clinical Innovation, Development Operations within Worldwide Research & Development at Pfizer. In this new role, Craig is working across units and stakeholders to define Pfizer’s vision for the future of clinical trials, and enabling the initiatives and investments to create that future. Most recently, Craig served as Venture Partner in Pfizer Venture Investments (Pfizer’s VC arm), where he focused on diversifying the company’s $50M annual budget for private investments in the areas of diagnostics and health technology. Craig was also Senior Director in Molecular Medicine, where he spearheaded initiatives driving innovation in clinical research and personalized medicines by drawing upon tools from health information technology, telemedicine, and eHealth. Craig brings over 15 years of leadership and innovation in the field of drug development. He previously served as Assoc Vice President of Program Management at Adnexus Therapeutics (acquired by Bristol-Myers Squibb), and on the founding management team for Perceptive Informatics (now part of PAREXEL International). Listed among the 2010 PharmaVOICE most inspiring people in the life sciences and among Pharmaceutical Executive’s 2011 Emerging Leaders, Craig was recently named program chair for the 2012 Annual Meeting of the Drug Information Association. Outside of Pfizer, Craig serves on the Board of Directors for the Foundation for Sarcoidosis Research.

Speaking on: The Risks and Rewards of Involving the e-Patient in Clinical Trial Research

 

Xavier Petit

Shire US

Within the Shire Integrated Marketing team, Xavier responsibilities include providing thought leadership, strategic and implementation recommendations to brands and business units on the use of emerging media, new marketing tactics and channels as well as identifying opportunities for improved efficiency and effectiveness across brands. Prior to joining Shire, Xavier worked at SAP where he was responsible for the North America Field Marketing Performance Management Program and at QVC where he was Manager of Consumer Data and Research.

Speaking on: Are You Mobile? The Impact of Mobile on Social Media

 

Samuel Dyer

MSL WORLD

Dr. Samuel Dyer is a dynamic skilled Medical Affairs professional with over 10 years experience within International Medical Affairs for a number of pharma companies. During his career, he has led MSL / Medical Teams in multiple TA’s in over 60 countries throughout the U.S., Canada, Europe, Africa, Middle East, New Zealand and Australia. His management experience includes small (2+) to large (240+) medical teams across multiple TA’s. Throughout his career, Dr. Dyer has worked on MSL and Medical strategy and has extensive experience in creating strategic MSL utilization and medical communication plans. He has designed, and created global MSL programs that have included: strategic assessments, planning, and execution in geographical locations with diverse cultures/languages. Dr. Dyer has been involved in the successful launch of both pharmaceutical and medical device products both in the U.S. and internationally. Over the years Dr. Dyer has developed an extensive international network within the Pharmaceutical, CRO, Medical Device, and Medical Communication industries. He has been an invited speaker at several conferences on various topics including creating MSL teams, international MSL teams, and the value of the MSL role. He has also worked as a consultant with a number of companies for Medical Affairs projects including recently with McKinsey Consulting and Bain and Co. Dr. Dyer is the CEO/founder and currently manages, with a team of professionals, www.MSLWORLD.com the industry’s first and only comprehensive interactive career management site 100% dedicated, focused and built to serve the Medical Science Liaison (MSL) career.

Speaking on: Case Study: How to Successfully Utilise Social Media to Connect a Global Community within Pharma

 

Serkan Erkovan

Boehringer Ingelheim

Serkan entered pharma industry with Boehringer Ingelheim Turkey in 2003 and successfully held cross functional roles with progressively greater responsibilities with history of achieving cost savings, enhancing system functionality and improving business processes. During business consultancy time; he had coordinated the local implementations of several sales & marketing projects and developed several award-winning projects in Key Opinion Leader Management and Customer Relationship Management. In 2011, he was appointed as IS Business Partner for Prescription Medicine, Consumer Health Care and Animal Health Sales & Marketing Businesses. Additionally, he’s responsible for all Online Activities, Social Media Affairs and Information Protection & Governance. He’s responsible for administration of local website, facebook and twitter pages and consulting business units for digital marketing projects, supplier management. Serkan holds an MBA degree from Kadir Has University, Istanbul and Business Informatics degree from Marmara University, Istanbul. More can be found at linkedin profile http://www.serkanerkovan.com

Speaking on: What’s Next for Pharma and Social Media?